Back
VictoryShares US Value Momentum ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
47
ULVM
VictoryShares US Value Momentum ETF
Last Price:
$93.00
Seasonality Move:
0.71%
Sell
37
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.08
Seasonality Move:
0.37%
Sell
47
VictoryShares US Value Momentum ETF (ULVM)
is a Sell
Is VictoryShares US Value Momentum ETF a Buy, Sell or Hold?
-
The current VictoryShares US Value Momentum ETF [ULVM] share price is $91.44. The Score for ULVM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ULVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.61. The Score for AMPH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ULVM Stock Price Chart
What is VictoryShares US Value Momentum ETF's stock price today?
-
The VictoryShares US Value Momentum ETF share price today is $91.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULVM is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.61The current trend is relatively stagnant and AMPH is experiencing slight selling pressure.
ULVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 53.47 | Buy |
| Chaikin Money Flow: | -1374 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.26 | Sell |
| Chaikin Money Flow: | -108584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.65 - 27.27) | Sell |
| Bollinger Bands (100): | (23.82 - 28.88) | Sell |
ULVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.76 | Sell |
| 20-day SMA: | 91.03 | Buy |
| 50-day SMA: | 90.24 | Buy |
| 200-day SMA: | 85.06 | Buy |
| 8-day EMA: | 91.74 | Sell |
| 20-day EMA: | 91.24 | Buy |
| 50-day EMA: | 88.67 | Buy |
| 200-day EMA: | 55.92 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.9 | Sell |
| 20-day SMA: | 26.41 | Sell |
| 50-day SMA: | 25.48 | Buy |
| 200-day SMA: | 25.65 | Sell |
| 8-day EMA: | 25.99 | Sell |
| 20-day EMA: | 26.16 | Sell |
| 50-day EMA: | 26.06 | Sell |
| 200-day EMA: | 27.93 | Sell |
VictoryShares US Value Momentum ETF Earnings Growth & ULVM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
VictoryShares US Value Momentum ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||